UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 368.


Agarwal, A; Kocjan, G; (2009) FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines. CYTOPATHOLOGY , 20 (2) 133 - 134. 10.1111/j.1365-2303.2008.00625.x.

Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.

Ahmed, N; Salsman, VS; Yvon, E; Louis, CU; Perlaky, L; Wels, WS; Dishop, MK; (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. MOLECULAR THERAPY , 17 (10) pp. 1779-1787. 10.1038/mt.2009.133.

Al-Qassab, H; Smith, MA; Irvine, EE; Guillermet-Guibert, J; Claret, M; Choudhury, AI; Selman, C; (2009) Dominant Role of the p110 beta Isoform of PI3K over p110 alpha in Energy Homeostasis Regulation by POMC and AgRP Neurons. CELL METAB , 10 (5) 343 - 354. 10.1016/j.cmet.2009.09.008. Gold open access

Altvater, B; Landmeier, S; Pscherer, S; Temme, J; Schweer, K; Kailayangiri, S; Campana, D; (2009) 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. CLINICAL CANCER RESEARCH , 15 (15) pp. 4857-4866. 10.1158/1078-0432.CCR-08-2810.

André, T; Boni, C; Navarro, M; Tabernero, J; Hickish, T; Topham, C; Bonetti, A; (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol , 27 (19) pp. 3109-3116. 10.1200/JCO.2008.20.6771.

Apostolidou, S; Hadwin, R; Burnell, M; Jones, A; Baff, D; Pyndiah, N; Mould, T; (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. INT J CANCER , 125 (12) 2995 - 3002. 10.1002/ijc.24745.

Arce, F; Rowe, HM; Chain, B; Lopes, L; Collins, MK; (2009) Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization. MOL THER , 17 (9) 1643 - 1650. 10.1038/mt.2009.149.

Arkenau, HT; (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol , 135 (7) pp. 855-866. 10.1007/s00432-009-0583-7.

Arkenau, HT; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2009) Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol , 27 (16) pp. 2692-2696. 10.1200/JCO.2008.19.5081.

Arkenau, HT; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; Judson, I; (2009) Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer. Oncology , 76 (3) pp. 151-156. 10.1159/000195884.

Averdam, A; Petersen, B; Rosner, C; Neff, J; Roos, C; Eberle, M; Aujard, F; (2009) A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates. PLOS GENET , 5 (10) , Article e1000688. 10.1371/journal.pgen.1000688. Green open access



Backdahl, L; Bushell, A; Beck, S; (2009) Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. INT J BIOCHEM CELL B , 41 (1) 176 - 184. 10.1016/j.biocel.2008.08.023.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. EPIGENETICS , 4 (4) 248 - 254.

Bajwa, A; Blunt, N; Vyas, S; Suliman, I; Bridgewater, J; Hochhauser, D; Ledermann, JA; (2009) Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. EJSO , 35 (2) 164 - 167. 10.1016/j.ejso.2008.06.005.

Balasubramaniam, T; Johnson, R; Cwynarski, K; Ackroyd, S; El-Sharkawi, D; Ashcroft, J; McNamara, C; (2009) Treatment outcomes of primary CNS lymphoma with IDARAM chemotherapy regime. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 14 - 14). WILEY-BLACKWELL PUBLISHING, INC

Balbi, KJ; Rocha, EP; Feil, EJ; (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol , 26 (2) pp. 345-355. 10.1093/molbev/msn252.

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; Marsh, P; (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Bartlett, JMS; Campbell, FM; Ibrahim, M; Wencyk, P; Ellis, I; Kay, E; Connolly, Y; (2009) Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH. AM J CLIN PATHOL , 132 (4) 514 - 520. 10.1309/AJCPXY3MJ6GSRCYP.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; (2009) HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , 15 (8) pp. 971-981. 10.1016/j.bbmt.2009.04.015.

Bazeos, A; Marin, D; Gerrard, G; Szydlo, R; Milojkovic, D; Reid, A; de Lavallade, H; (2009) BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1258). AMER SOC HEMATOLOGY

Behjati, S; Bamfo, JEAK; Bates, AW; Veerareddy, S; (2009) A near miss: Lessons from a case of omental pregnancy. J OBSTET GYNAECOL , 29 (6) 559 - 560. 10.1080/01443610902984946.

Behjati, S; Zilbauer, M; Heuschkel, R; Phillips, A; Salvestrini, C; Torrente, F; Bates, AW; (2009) Defining Eosinophilic Colitis in Children: Insights From a Retrospective Case Series. J PEDIATR GASTR NUTR , 49 (2) 208 - 215.

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. GENOME MEDICINE , 1 (ARTN 56) 10.1186/gm56.

Bell, CG; Wood, DR; Cheong, SJ; Kwan, E; Sinosich, M; Delprado, W; Baumgart, KW; (2009) Molecular confirmation of pathological specimen integrity in Australasia. Pathology , 41 (3) pp. 280-283. 10.1080/00313020902756311.

Bellodi, C; Lidonnici, MR; Hamilton, A; Helgason, GV; Soliera, AR; Ronchetti, M; Galavotti, S; (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J CLIN INVEST , 119 (5) 1109 - 1123. 10.1172/JCI35660.

Bendall, SC; Hughes, C; Campbell, JL; Stewart, MH; Pittock, P; Liu, S; Bonneil, E; (2009) An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture. MOLECULAR & CELLULAR PROTEOMICS , 8 (3) pp. 421-432. 10.1074/mcp.M800190-MCP200.

Berenjeno, IM; Vanhaesebroeck, B; (2009) PI3K regulatory subunits lose control in cancer. Cancer Cell , 16 (6) pp. 449-450. 10.1016/j.ccr.2009.11.017.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Pompella, A; Corti, A; Huaux, FA; (2009) Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells. AM J RESP CELL MOL , 41 (2) 199 - 206. 10.1165/rcmb.2008-0013OC.

Bhosle, J; Makris, A; Hartley, J; Hochhauser, D; (2009) Modulation of topoisomerase II\#945; poison induced DNA damage and repair by tyrosine kinase inhibitiors. CANCER RESEARCH , 69

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Boone, JJM; Bhosle, J; Tilby, MJ; Hartley, JA; Hochhauser, D; (2009) Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. MOL CANCER THER , 8 (11) 3015 - 3023. 10.1158/1535-7163.MCT-09-0219.

Boshoff, C; Posner, M; (2009) Targeting EGFR in head and neck cancer: a decade of progress. NAT CLIN PRACT ONCOL , 6 (3) 123 - 123. 10.1038/ncponc1328.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; Gale, RE; (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Bowers, SR; Mirabella, F; Calero-Nieto, FJ; Valeaux, S; Hadjur, S; Baxter, EW; Merkenschlager, M; (2009) A Conserved Insulator That Recruits CTCF and Cohesin Exists between the Closely Related but Divergently Regulated Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor Genes. MOL CELL BIOL , 29 (7) 1682 - 1693. 10.1128/MCB.01411-08.

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. BLOOD , 114 (23) pp. 4792-4803. 10.1182/blood-2009-07-228387.

Brown, AC; Hallouane, D; Mawby, WJ; Karet, FE; Saleem, MA; Howie, AJ; Toye, AM; (2009) RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels. Am J Physiol Renal Physiol , 296 (6) F1279-F1290. 10.1152/ajprenal.00013.2009.

Bruce, AW; Lopez-Contreras, AJ; Flicek, P; Down, TA; Dhami, P; Dillon, SC; Koch, CM; (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. GENOME RES , 19 (6) 994 - 1005. 10.1101/gr.089086.108.

Brunelli, M; Manfrin, E; Martignoni, G; Miller, K; Remo, A; Reghellin, D; Bersani, S; (2009) Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. AM J CLIN PATHOL , 131 (5) 678 - 682. 10.1309/AJCP09VUTZWZXBMJ.

Bruno, L; Mazzarella, L; Hoogenkamp, M; Hertweck, A; Cobb, BS; Sauer, S; Hadjur, S; (2009) Runx proteins regulate Foxp3 expression. J EXP MED , 206 (11) 2329 - 2337. 10.1084/jem.20090226.


Calvaruso, V; Burroughs, AK; Standish, R; Manousou, P; Grillo, F; Leandro, G; Maimone, S; (2009) Computer-Assisted Image Analysis of Liver Collagen: Relationship to Ishak Scoring and Hepatic Venous Pressure Gradient. HEPATOLOGY , 49 (4) 1236 - 1244. 10.1002/hep.22745.

Cave, J; Edwards, SG; Miller, RF; Ardeshna, KM; Lee, SM; (2009) Should we implement 'opt-out' HIV testing for patients with lymphoma? CLIN MED , 9 (4) 320 - 322.

Chacko, S; Taskapan, H; Roscoe, J; Stein, J; Woods, E; Denton, T; Ting, R; (2009) Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature. Clin Nephrol , 72 (5) pp. 414-417.

Chan, CF; Gatehouse, PD; Hughes, R; Roughton, M; Pennell, DJ; Firmin, DN; (2009) Novel Technique Used to Detect Swallowing in Volume-Selective Turbo Spin-Echo (TSE) for Carotid Artery Wall Imaging. J MAGN RESON IMAGING , 29 (1) 211 - 216. 10.1002/jmri.21607.


Chapgier, A; Kong, XF; Boisson-Dupuis, S; Jouanguy, E; Averbuch, D; Feinberg, J; Zhang, SY; (2009) A partial form of recessive STAT1 deficiency in humans. J Clin Invest , 119 (6) pp. 1502-1514. 10.1172/JCI37083.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion , 49 (3) pp. 440-452. 10.1111/j.1537-2995.2008.01948.x.

Cheng, YY; Siddle, HV; Beck, S; Eldridge, MDB; Belov, K; (2009) High levels of genetic variation at MHC class II DBB loci in the tammar wallaby (Macropus eugenii). IMMUNOGENETICS , 61 (2) 111 - 118. 10.1007/s00251-008-0347-6.

Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM; (2009) Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature , 460 (7251) pp. 123-127. 10.1038/nature08087.

Chickarmane, V; Enver, T; Peterson, C; (2009) Computational Modeling of the Hematopoietic Erythroid-Myeloid Switch Reveals Insights into Cooperativity, Priming, and Irreversibility. PLOS COMPUT BIOL , 5 (1) , Article e1000268. 10.1371/journal.pcbi.1000268. Green open access

Chua, MLK; Kamis, HB; Loong, SL; (2009) In vitro interaction of cyclooxygenase-2 (COX-2) inhibitors with radiation in nasopharyngeal carcinoma: dependent on sequence of administration. In: ORAL ONCOLOGY. (pp. 236 - 236). ELSEVIER SCIENCE BV


Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, S-F; Stein, RC; Ellis, IO; (2009) The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. ONCOGENE , 28 (46) pp. 4041-4052. 10.1038/onc.2009.259.

Cliffe, ST; Kramer, JM; Hussain, K; Robben, JH; de Jong, EK; de Brouwer, AP; Nibbeling, E; (2009) SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. HUM MOL GENET , 18 (12) 2257 - 2265. 10.1093/hmg/ddp161.

Cohen-Solal, A; Kotecha, D; van Veldhuisen, DJ; Babalis, D; Bohm, M; Coats, AJ; Roughton, M; (2009) Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. EUR J HEART FAIL , 11 (9) 872 - 880. 10.1093/eurjhf/hfp104.

Constantinou, A; Epenetos, AA; Hreczuk-Hirst, D; Jain, S; Wright, M; Chester, KA; Deonarain, MP; (2009) Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment. BIOCONJUGATE CHEM , 20 (5) 924 - 931. 10.1021/bc8005122.

Cooley, S; Trachtenberg, E; Bergemann, TL; Saeteurn, K; Klein, J; Le, CT; Marsh, SGE; (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. BLOOD , 113 (3) pp. 726-732. 10.1182/blood-2008-07-171926.

Cunningham, D; Sirohi, B; Pluzanska, A; Utracka-Hutka, B; Zaluski, J; Glynne-Jones, R; Koralewski, P; (2009) Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. Ann Oncol , 20 (2) pp. 244-250. 10.1093/annonc/mdn638.


Dalby, M; Kharbanda, R; Ghimire, G; Spiro, J; Moore, P; Roughton, M; Lane, R; (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. AM HEART J , 158 (5) 829 - 835. 10.1016/j.ahj.2009.08.012.

Dancey, G; Begent, RH; Meyer, T; (2009) Imaging in targeted delivery of therapy to cancer. TARGET ONCOL , 4 (3) 201 - 217. 10.1007/s11523-009-0119-8.

Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; Othman, S; (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.

Dar, O; Riley, J; Chapman, C; Dubrey, SW; Morris, S; Rosen, SD; Roughton, M; (2009) A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. EUR J HEART FAIL , 11 (3) 319 - 325. 10.1093/eurjhf/hfn050.

Dearling, JLJ; Flynn, AA; Qureshi, U; Whiting, S; Boxer, GM; Green, A; Begent, RHJ; (2009) Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake. NUCL MED BIOL , 36 (8) 883 - 894. 10.1016/j.nucmedbio.2009.07.003.

Delaney, D; Diss, TC; Presneau, N; Hing, S; Berisha, F; Idowu, BD; O'Donnell, P; (2009) GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. MODERN PATHOL , 22 (5) 718 - 724. 10.1038/modpathol.2009.32.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; Galy, A; (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) pp. 3666-3676. 10.1002/pmic.200800747.

Dennis, MY; Paracchini, S; Scerri, TS; Prokunina-Olsson, L; Knight, JC; Wade-Martins, R; Coggill, P; (2009) A Common Variant Associated with Dyslexia Reduces Expression of the KIAA0319 Gene. PLOS GENET , 5 (3) , Article e1000436. 10.1371/journal.pgen.1000436. Green open access

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; Treleaven, JG; (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

Ding, XY; Patel, M; Shen, DF; Herzlich, AA; Cao, XG; Villasmil, R; Klupsch, K; (2009) Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration. INVEST OPHTH VIS SCI , 50 (10) 4957 - 4966. 10.1167/iovs.09-3381.

Dovey, CL; Aslanian, A; Sofueva, S; Yates, JR; Russell, P; (2009) Mms1-Mms22 complex protects genome integrity in Schizosaccharomyces pombe. DNA REPAIR , 8 (12) 1390 - 1399. 10.1016/j.dnarep.2009.09.008.

Dulev, S; de Renty, C; Mehta, R; Minkov, I; Schwob, E; Strunnikov, A; (2009) Essential global role of CDC14 in DNA synthesis revealed by chromosome underreplication unrecognized by checkpoints in cdc14 mutants. Proc Natl Acad Sci U S A , 106 (34) pp. 14466-14471. 10.1073/pnas.0900190106.


Durand, CA; Hartvigsen, K; Fogelstrand, L; Kim, S; Iritani, S; Vanhaesebroeck, B; Witztum, JL; (2009) Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol , 183 (9) pp. 5673-5684. 10.4049/jimmunol.0900432.


Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) pp. 2-6. 10.1016/j.bbmt.2008.10.013.

El-Mehidi, N.S.; (2009) Bayesian network models of interdependent chromosomal aberrations in unstable cancer genomes. Doctoral thesis, UCL (University College London).

Emuss, V; Lagos, D; Pizzey, A; Gratrix, F; Henderson, SR; Boshoff, C; (2009) KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia. PLoS Pathogens , 5 (10) , Article e1000616. 10.1371/journal.ppat.1000616. Green open access

Enver, T; Jacobsen, SEW; (2009) DEVELOPMENTAL BIOLOGY Instructions writ in blood. NATURE , 461 (7261) pp. 183-184. 10.1038/461183a.

Enver, T; Pera, M; Peterson, C; Andrews, PW; (2009) Stem Cell States, Fates, and the Rules of Attraction. CELL STEM CELL , 4 (5) pp. 387-397. 10.1016/j.stem.2009.04.011.

Essafi, A; Gomes, AR; Pomeranz, KM; Zwolinska, AK; Varshochi, R; McGovern, UB; Lam, EW; (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol Biol , 462 pp. 201-211. 10.1007/978-1-60327-115-8_13.

Everington, T.; (2009) Investigation of the molecular and functional pathophysiology of polycythaemia vera. Doctoral thesis, UCL (University College London).


Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; Marks, DI; (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Fiore, MM; Mackie, IJ; (2009) Dual effect of Platelet Factor 4 on the activities of Factor Xa. BIOCHEM BIOPH RES CO , 379 (4) 1072 - 1075. 10.1016/j.bbrc.2009.01.016.

Fiore, MM; Mackie, IM; (2009) Mechanism of low-molecular-weight heparin reversal by platelet factor 4. THROMBOSIS RESEARCH , 124 (1) pp. 149-155. 10.1016/j.thromres.2008.12.047.

Flanagan, JM; Funes, JM; Henderson, S; Wild, L; Carey, N; Boshoff, C; (2009) Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. MOL CANCER THER , 8 (1) 249 - 260. 10.1158/1535-7163.MCT-08-0636.

Flanagan, JM; Munoz-Alegre, M; Henderson, S; Tang, T; Sun, P; Johnson, N; Fletcher, O; (2009) Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. HUM MOL GENET , 18 (7) 1332 - 1342. 10.1093/hmg/ddp033.

Ford, AM; Palmi, C; Bueno, C; Hong, D; Cardus, P; Knight, D; Cazzaniga, G; (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. JOURNAL OF CLINICAL INVESTIGATION , 119 (4) pp. 826-836. 10.1172/JCI36428.

Foroni, L; Gerrard, G; Nna, E; Khorashad, JS; Stevens, D; Swale, B; Milojkovic, D; (2009) Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY , 84 (8) pp. 517-522. 10.1002/ajh.21457.

Forshew, T; Tatevossian, RG; Lawson, AR; Ma, J; Neale, G; Ogunkolade, BW; Jones, TA; (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol , 218 (2) pp. 172-181. 10.1002/path.2558.

Fox, J; Patkar, V; Chronakis, I; Begent, R; (2009) From practice guidelines to clinical decision support: closing the loop. J ROY SOC MED , 102 (11) 464 - 473. 10.1258/jrsm.2009.090010.

Francis, RE; Myatt, SS; Krol, J; Hartman, J; Peck, B; McGovern, UB; Wang, J; (2009) FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol , 35 (1) pp. 57-68.


Gancheva, K; Postadjian, A; Brazma, D; Grace, C; Chanalaris, A; Nacheva, E; Apostolova, MD; (2009) COPY NUMBER VARIANTS: DISTRIBUTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS. BIOTECHNOL BIOTEC EQ , 23 (1) 1095 - 1100.

Gandhi, S; Wood-Kaczmar, A; Yao, Z; Plun-Favreau, H; Deas, E; Klupsch, K; Downward, J; (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death. MOL CELL , 33 (5) 627 - 638. 10.1016/j.molcel.2009.02.013. Gold open access

Garbowski, MW; Carpenter, JP; Smith, G; Pennell, DJ; Porter, JB; (2009) Calibration of Improved T2*Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. In: BLOOD. (pp. 791 - 791). AMER SOC HEMATOLOGY

Gardiner, C; Longair, I; Pescott, MA; Erwin, H; Hills, J; Machin, SJ; Cohen, H; (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? Journal of Clinical Pathology , 62 (2) 168 - 171. 10.1136/jcp.2008.059634. Green open access

Garofalo, M; Di Leva, G; Romano, G; Nuovo, G; Suh, SS; Ngankeu, A; Taccioli, C; (2009) miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. CANCER CELL , 16 (6) 498 - 509. 10.1016/j.ccr.2009.10.014.

Gaya, A.M.; (2009) Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P). Doctoral thesis, UCL (University College London). Green open access

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. EUROPEAN JOURNAL OF PHARMACOLOGY , 609 (1-3) pp. 34-39. 10.1016/j.ejphar.2009.03.018.

Ghimire, G; Spiro, J; Kharbanda, R; Roughton, M; Barlis, P; Mason, M; Ilsley, C; (2009) Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention , 4 (4) pp. 481-484.

Ghosh, AK; Shanafelt, TD; Cimmino, A; Taccioli, C; Volinia, S; Liu, CG; Calin, GA; (2009) Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. BLOOD , 113 (22) 5568 - 5574. 10.1182/blood-2008-10-185686.

Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E; (2009) Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility. NAT CELL BIOL , 11 (11) 1287 - U49. 10.1038/ncb1973.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS (c)-YG study. EUR J ONCOL NURS , 13 (3) 187 - 192. 10.1016/j.ejon.2009.03.004.

Gollmer, K; Asperti-Boursin, F; Tanaka, Y; Okkenhaug, K; Vanhaesebroeck, B; Peterson, JR; Fukui, Y; (2009) CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood , 114 (3) pp. 580-588. 10.1182/blood-2009-01-200923.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. BLOOD , 113 (18) pp. 4381-4390. 10.1182/blood-2008-08-174748.

Graf, T; Enver, T; (2009) Forcing cells to change lineages. NATURE , 462 (7273) pp. 587-594. 10.1038/nature08533.

Griffin, N; Adams, S; Inglott, S; Chatters, S; Qureshi, A; Goulden, N; Ancliff, P; (2009) FLT3-ITD mutations as a prognostic factor in children with AML - experience in a uniformly treated, large, single centre cohort. British Journal of Haematology , 145 117-.

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; Diverio, D; (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Grun, B; Benjamin, E; Sinclair, J; Timms, JF; Jacobs, IJ; Gayther, SA; Dafou, D; (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. CELL PROLIFERAT , 42 (2) 219 - 228. 10.1111/j.1365-2184.2008.00579.x.

Gunaratnam, M; Swank, S; Haider, SM; Galesa, K; Reszka, AP; Beltran, M; Cuenca, F; (2009) Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. J Med Chem , 52 (12) pp. 3774-3783. 10.1021/jm900424a.

Gupta, R; Vyas, P; Enver, T; (2009) Molecular Targeting of Cancer Stem Cells. CELL STEM CELL , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.


Hackshaw, A; Baum, M; Fornander, T; Nordenskjold, B; Nicolucci, A; Monson, K; Forsyth, S; (2009) Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer. J NATL CANCER I , 101 (5) 341 - 349. 10.1093/jnci/djn498. Green open access

Hadjur, S; Bruno, L; Hertweck, A; Cobb, BS; Taylor, B; Fisher, AG; Merkenschlager, M; (2009) IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1. IMMUNOL LETT , 122 (1) 37 - 43. 10.1016/j.imlet.2008.11.001.

Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; Fisher, AG; (2009) Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. NATURE , 460 (7253) 410 - U130. 10.1038/nature08079.

Hancock, BW; Qian, W; Linch, D; Delchier, J-C; Smith, P; Jakupovic, I; Burton, C; (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. BRITISH JOURNAL OF HAEMATOLOGY , 144 (3) pp. 367-375. 10.1111/j.1365-2141.2008.07486.x.

Harten, SK; Shukla, D; Barod, R; Hergovich, A; Balda, MS; Matter, K; Esteban, MA; (2009) Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin. MOL BIOL CELL , 20 (3) 1089 - 1101. 10.1091/mbc.E08-06-0566.

Hatton, CSR; Peniket, A; Tusold, A; Collins, GP; Joyner, M; Lee, R; Mouncey, P; (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 13). WILEY-BLACKWELL PUBLISHING, INC

Hergovich, A; Hemmings, BA; (2009) Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. BIOFACTORS , 35 (4) 338 - 345. 10.1002/biof.47.

Hergovich, A; Kohler, RS; Schmitz, D; Vichalkovski, A; Cornils, H; Hemmings, BA; (2009) The MST1 and hMOB1 Tumor Suppressors Control Human Centrosome Duplication by Regulating NDR Kinase Phosphorylation. CURR BIOL , 19 (20) 1692 - 1702. 10.1016/j.cub.2009.09.020.

Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; Cobb, M; (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.

Holdsworth, R; Hurley, CK; Marsh, SGE; Lau, M; Noreen, HJ; Kempenich, JH; Setterholm, M; (2009) The HLA dictionary 2008: a summary of HLA-A, -B, -C,-DRB1/3/4/5, and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. TISSUE ANTIGENS , 73 (2) pp. 95-170. 10.1111/j.1399-0039.2008.01183.x.

Hoskin, PJ; Lowry, L; Horwich, A; Jack, A; Mead, B; Hancock, BW; Smith, P; (2009) Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. In: (Proceedings) 50th Annual Meeting of the American-Society-of-Hematology. (pp. pp. 5390-5396). AMER SOC CLINICAL ONCOLOGY

Howie, AJ; Brewer, DB; (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron , 40 (3) pp. 285-301. 10.1016/j.micron.2008.10.002.

Huang, Y; Moreau, A; Dupuis, J; Streubel, B; Petit, B; Le Gouill, S; Martin-Garcia, N; (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol , 33 (5) pp. 682-690. 10.1097/PAS.0b013e3181971591.

Hubacek, P; Virgili, A; Ward, KN; Pohlreich, D; Keslova, P; Goldova, B; Markova, M; (2009) HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. BRIT J HAEMATOL , 145 (3) 394 - 398. 10.1111/j.1365-2141.2009.07622.x.

Hubbard, TJP; Aken, BL; Ayling, S; Ballester, B; Beal, K; Bragin, E; Brent, S; (2009) Ensembl 2009. NUCLEIC ACIDS RESEARCH , 37 D690-D697. 10.1093/nar/gkn828. Gold open access

Hughes, C; Mcewan, JR; Longair, I; Hughes, S; Cohen, H; Machin, S; Scully, M; (2009) Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J THROMB HAEMOST , 7 (4) 529 - 536. 10.1111/j.1538-7836.2009.03285.x.

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

Hussain, K; Padidela, R; Kapoor, RR; James, C; Banerjee, K; Harper, J; Wilson, LC; (2009) Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: confirmation of a syndrome. PEDIATR DIABETES , 10 (3) 193 - 197. 10.1111/j.1399-5448.2008.00470.x.




James, C; Kapoor, RR; Ismail, D; Hussain, K; (2009) The genetic basis of congenital hyperinsulinism. J MED GENET , 46 (5) 289 - 299. 10.1136/jmg.2008.064337.

Jenner, RG; Townsend, MJ; Jackson, I; Sun, KM; Bouwman, RD; Young, RA; Glimcher, LH; (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. P NATL ACAD SCI USA , 106 (42) 17876 - 17881. 10.1073/pnas.0909357106. Gold open access

Joly, P; Jennings, BH; Jayasinghe, SN; (2009) Development and fertility studies on post-bio-electrosprayed Drosophila melanogaster embryos. BIOMICROFLUIDICS , 3 (4) , Article 044107. 10.1063/1.3267044.


Kalambokis, G; Manousou, P; Samonakis, D; Grillo, F; Dhillon, AP; Patch, D; O'Beirne, J; (2009) Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient. TRANSPL INT , 22 (2) 172 - 181. 10.1111/j.1432-2277.2008.00744.x.

Kapoor, RR; Flanagan, SE; James, C; Shield, J; Ellard, S; Hussain, K; (2009) Hyperinsulinaemic hypoglycaemia. ARCH DIS CHILD , 94 (6) 450 - 457. 10.1136/adc.2008.148171.

Kapoor, RR; James, C; Flanagan, SE; Ellard, S; Eaton, S; Hussain, K; (2009) 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency and Hyperinsulinemic Hypoglycemia: Characterization of a Novel Mutation and Severe Dietary Protein Sensitivity. J CLIN ENDOCR METAB , 94 (7) 2221 - 2225. 10.1210/jc.2009-0423.

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. NAT CLIN PRACT ENDOC , 5 (2) 101 - 112. 10.1038/ncpendmet1046.

Kapoor, RR; James, C; Hussain, K; (2009) Hyperinsulinism in Developmental Syndromes. ENDOCRINE INVOLVEMENT IN DEVELOPMENTAL SYNDROMES , 14 95 - 113.

Kaput, J; Cotton, RGH; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; (2009) Planning the Human Variome Project: The Spain Report. HUM MUTAT , 30 (4) 496 - 510. 10.1002/humu.20972.


Kayes, OJ; Loddo, M; Patel, N; Patel, P; Minhas, S; Ambler, G; Freeman, A; (2009) DNA Replication Licensing Factors and Aneuploidy Are Linked to Tumor Cell Cycle State and Clinical Outcome in Penile Carcinoma. CLIN CANCER RES , 15 (23) 7335 - 7344. 10.1158/1078-0432.CCR-09-0882.

Keenan, NG; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Hooper, J; Firmin, DN; (2009) Magnetic resonance of carotid artery ageing in healthy subjects. ATHEROSCLEROSIS , 205 (1) 168 - 173. 10.1016/j.atherosclerosis.2008.11.018.

Kelleher, MT; Fruhwirth, G; Patel, G; Ofo, E; Festy, F; Barber, PR; Ameer-Beg, SM; (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol , 4 (3) pp. 235-252. 10.1007/s11523-009-0116-y.

Ketchell, RI; Roughton, M; Agent, P; Gyi, K; Hodson, ME; (2009) Predicting survival in end-stage cystic fibrosis. RESP MED , 103 (10) 1441 - 1447. 10.1016/j.rmed.2009.04.025.

Khorashad, JS; Wagner, S; Greener, L; Marin, D; Reid, A; Milojkovic, D; Patel, H; (2009) The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 94 (6) pp. 861-864. 10.3324/haematol.2008.003715.

Kim, BS; Miyagawa, F; Cho, Y-H; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (12) pp. 2805-2817. 10.1038/jid.2009.176.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; Salomoni, P; (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. ONCOGENE , 28 (39) 3499 - 3512. 10.1038/onc.2009.191.

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; Smith, P; (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Kocjan, G; Ramsay, A; Beale, T; O'Flynn, P; (2009) Head and neck cancer in the UK: what is expected of cytopathology? CYTOPATHOLOGY , 20 (2) 69 - 77. 10.1111/j.1365-2303.2009.00647.x.

Kok, K; Geering, B; Vanhaesebroeck, B; (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci , 34 (3) pp. 115-127. 10.1016/j.tibs.2009.01.003.

Kok, K; Nock, GE; Verrall, EA; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B; (2009) Regulation of p110δ PI 3-Kinase Gene Expression. PLoS One , 4 (4) , Article e5145. 10.1371/journal.pone.0005145. Green open access

Kolman, P; Pica, A; Carvou, N; Boyde, A; Cockcroft, S; Loesch, A; Pizzey, A; (2009) Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro. AM J PHYSIOL-RENAL , 296 (5) F1227 - F1237. 10.1152/ajprenal.90351.2008.

Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; Bouriez-Jones, T; (2009) Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells. CELL STEM CELL , 5 (6) pp. 659-665. 10.1016/j.stem.2009.11.001.

Kristeleit, R; O'Brien, M; (2009) Cardiotoxicity from cytotoxics in the 21st century. British Journal of Cardiology , 16 (2) pp. 60-62.

Kulkarni, AA; Kingsbury, SR; Tudzarova, S; Hong, HK; Loddo, M; Rashid, M; Rodriguez-Acebes, S; (2009) Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma. CLIN CANCER RES , 15 (7) 2417 - 2425. 10.1158/1078-0432.CCR-08-1276.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT, ; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.


Lacombe, T; García-Gómez, JJ; de la Cruz, J; Roser, D; Hurt, E; Linder, P; Kressler, D; (2009) Linear ubiquitin fusion to Rps31 and its subsequent cleavage are required for the efficient production and functional integrity of 40S ribosomal subunits. Mol Microbiol , 72 (1) pp. 69-84. 10.1111/j.1365-2958.2009.06622.x.

Lajiness, J; Sielaff, A; MacKay, H; Brown, T; Kluza, J; Nguyen, B; Wilson, WD; (2009) Polyamide Curvature and DNA Sequence Selective Recognition: Use of 4-Aminobenzamide to Adjust Curvature. MED CHEM , 5 (3) 216 - 226.

Lambert, JR; Everington, T; Linch, DC; Gale, RE; (2009) In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. BLOOD , 114 (14) 3018 - 3023. 10.1182/blood-2009-03-209916.

Lambert, JR; Gale, RE; Linch, DC; (2009) The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia. BRIT J HAEMATOL , 145 (1) 128 - 130. 10.1111/j.1365-2141.2009.07597.x.

Lau-Walker, MO; Cowie, MR; Roughton, M; (2009) Coronary heart disease patients' perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge. J CLIN NURS , 18 (1) 63 - 71. 10.1111/j.1365-2702.2008.02386.x.

Lawrenson, K; Benjamin, E; Turmaine, M; Jacobs, I; Gayther, S; Dafou, D; (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. CELL PROLIFERAT , 42 (3) 385 - 393. 10.1111/j.1365-2184.2009.00604.x.

Lawrie, AS; Albanyan, A; Cardigan, RA; Mackie, IJ; Harrison, P; (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. VOX SANG , 96 (3) 206 - 212. 10.1111/j.1423-0410.2008.01151.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35-. 10.1186/1472-6750-9-35.

Ledermann, JA; Stebbing, J; (2009) Positioning pemetrexed in the treatment of ovarian cancer. EUR J CANCER , 45 (8) 1330 - 1332. 10.1016/j.ejca.2009.02.006.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Lee, SM; James, LE; Qian, W; Spiro, S; Eisen, T; Gower, NH; Ferry, DR; (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. THORAX , 64 (1) pp. 75-80. 10.1136/thx.2007.093872.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; Spiro, S; (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. J Clin Oncol , 27 (31) pp. 5248-5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; Spiro, S; (2009) Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. JOURNAL OF THE NATIONAL CANCER INSTITUTE , 101 (15) pp. 1049-1057. 10.1093/jnci/djp200.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; Spiro, S; (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) pp. 1049-1057. 10.1093/jnci/djp200. Green open access

Leedham, SJ; Graham, TA; Oukrif, D; McDonald, SAC; Rodriguez-Justo, M; Harrison, RF; Shepherd, NA; (2009) Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia. GASTROENTEROLOGY , 136 (2) 542 - 550. 10.1053/j.gastro.2008.10.086.

Lhériteau, E; Libeau, L; Stieger, K; Deschamps, JY; Mendes-Madeira, A; Provost, N; Lemoine, F; (2009) The RPGRIP1-deficient dog, a promising canine model for gene therapy. Mol Vis , 15 pp. 349-361.

Li, W; Ferguson, BJ; Khaled, WT; Tevendale, M; Stingl, J; Poli, V; Rich, T; (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. P NATL ACAD SCI USA , 106 (12) 4725 - 4730. 10.1073/pnas.0807640106.

Liu, D; Zhang, T; Marshall, AJ; Okkenhaug, K; Vanhaesebroeck, B; Uzonna, JE; (2009) The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol , 183 (3) pp. 1921-1933. 10.4049/jimmunol.0901099.

Liu, ML; Liu, MJ; Shen, YF; Ryu, H; Kim, HJ; Klupsch, K; Downward, J; (2009) Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. J CELL SCI , 122 (11) 1917 - 1926. 10.1242/jcs.042226.

Loddo, M; Kingsbur, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El Sheikh, S; (2009) Cell cycle phase progression analysis identifies unique replication phenotypes of major prognostic and predictive significance in cancer. In: CANCER RESEARCH. (pp. 320S - 320S). AMER ASSOC CANCER RESEARCH

Loddo, M; Kingsbury, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El-Sheikh, S; (2009) Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. BRIT J CANCER , 100 (6) 959 - 970. 10.1038/sj.bjc.6604924.

Loong, SLE; Hwang, JSG; Li, HH; Wee, JTS; Yap, SP; Chua, MLK; Fong, KW; (2009) Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). RADIAT ONCOL , 4 , Article 23. 10.1186/1748-717X-4-23.

Lopez, MN; Pereda, C; Segal, G; Munoz, L; Aguilera, R; Gonzalez, FE; Escobar, A; (2009) Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells. J CLIN ONCOL , 27 (6) 945 - 952. 10.1200/JCO.2008.18.0794.

Lorenz, A; Osman, F; Folkyte, V; Sofueva, S; Whitby, MC; (2009) Fbh1 Limits Rad51-Dependent Recombination at Blocked Replication Forks. MOL CELL BIOL , 29 (17) 4742 - 4756. 10.1128/MCB.00471-09.

Lugli, E; Ferraresi, R; Roat, E; Troiano, L; Pinti, M; Nasi, M; Nemes, E; (2009) Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. LEUKEMIA RES , 33 (1) 140 - 150. 10.1016/j.leukres.2008.07.025.


Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Mackenzie, GD; Dunn, JM; Selvasekar, CR; Mosse, CA; Thorpe, SM; Novelli, MR; Bown, SG; (2009) Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. LASER MED SCI , 24 (5) 729 - 734. 10.1007/s10103-008-0630-7.

Maniaci, V; Davidson, BR; Rolles, K; Dhillon, AP; Hackshaw, A; Begent, RH; Meyer, T; (2009) Fibrolamellar hepatocellular carcinoma - Prolonged survival with multimodality therapy. EJSO-EUR J SURG ONC , 35 (6) 617 - 621. 10.1016/j.ejso.2008.12.009.



Manousou, P; Samonakis, D; Cholongitas, E; Patch, D; O'Beirne, J; Dhillon, AP; Rolles, K; (2009) Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy. LIVER TRANSPLANT , 15 (12) 1783 - 1791. 10.1002/lt.21907.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. EXPERT REVIEW OF HEMATOLOGY , 2 (2) pp. 133-136. 10.1586/EHM.09.3.

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; (2009) Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. J CLIN ONCOL , 27 (26) 4352 - 4356. 10.1200/JCO.2009.22.0996.

Mantovani, J; Charrier, S; Eckenberg, R; Saurin, W; Danos, O; Perea, J; Galy, A; (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med , 11 (8) pp. 645-654. 10.1002/jgm.1346.

Marelli, L; Shusang, V; Buscombe, JR; Cholongitas, E; Stigliano, R; Davies, N; Tibballs, J; (2009) Transarterial Injection of I-131-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer. JOURNAL OF NUCLEAR MEDICINE , 50 (6) pp. 871-877. 10.2967/jnumed.108.060558.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; Ferrando, A; (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update April 2009. TISSUE ANTIGENS , 74 (3) pp. 272-275. 10.1111/j.1399-0039.2009.01322.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update August 2008. TISSUE ANTIGENS , 73 (1) pp. 91-92. 10.1111/j.1399-0039.2008.01165.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update December 2008. TISSUE ANTIGENS , 73 (6) pp. 629-631. 10.1111/j.1399-0039.2009.01242.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update February 2009. TISSUE ANTIGENS , 74 (2) pp. 180-182. 10.1111/j.1399-0039.2009.01285.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update January 2009. TISSUE ANTIGENS , 74 (2) pp. 177-179. 10.1111/j.1399-0039.2009.01284.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update July 2008. TISSUE ANTIGENS , 73 (1) pp. 88-90. 10.1111/j.1399-0039.2008.01164.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update June 2009. TISSUE ANTIGENS , 74 (4) pp. 364-366. 10.1111/j.1399-0039.2009.01330.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update March 2009. TISSUE ANTIGENS , 74 (2) pp. 183-186. 10.1111/j.1399-0039.2009.01288.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update May 2009. TISSUE ANTIGENS , 74 (4) pp. 358-363. 10.1111/j.1399-0039.2009.01321.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update November 2008. TISSUE ANTIGENS , 73 (4) pp. 383-384. 10.1111/j.1399-0039.2009.01212.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update October 2008. TISSUE ANTIGENS , 73 (4) pp. 381-382. 10.1111/j.1399-0039.2009.01211.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update September 2008. TISSUE ANTIGENS , 73 (1) pp. 93-94. 10.1111/j.1399-0039.2008.01169.x.

Martín Caballero, I; Hansen, J; Leaford, D; Pollard, S; Hendrich, BD; (2009) The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation. PLoS One , 4 (1) , Article e4315. 10.1371/journal.pone.0004315. Green open access

Masir, N; Campbell, LJ; Goff, LK; Jones, M; Marafioti, T; Cordell, J; Clear, AJ; (2009) BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations. Br J Haematol , 144 (5) pp. 716-725. 10.1111/j.1365-2141.2008.07528.x.

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) Predicting disease relapse using NOD2/CARD15 SNP5 and HLA-DPB1 matching status. INT J IMMUNOGENET , 36 (5) 317 - 318.

McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A; (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene , 28 (11) pp. 1465-1470. 10.1038/onc.2008.483.

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

McDermott, AB; Cohen, SBA; Zuckerman, JN; Madrigal, JA; (2009) Hepatitis B third generation vaccines: improves response and conventional vaccine non-response - evidence for genetic basis in man. Journal of Viral Hepatitis , 5 pp. 9-11.

McDonald, V; Laffan, M; Benjamin, S; Bevan, D; Machin, S; Scully, MA; (2009) Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. BRIT J HAEMATOL , 144 (3) 430 - 433. 10.1111/j.1365-2141.2008.07458.x.

McDonald, V; Leandro, M; (2009) Rituximab in non-haematological disorders of adults and its mode of action. BRIT J HAEMATOL , 146 (3) 233 - 246. 10.1111/j.1365-2141.2009.07718.x.

McDonald, V; Scully, M; Manns, K; Mackie, IJ; Machin, SJ; (2009) Serum rituximab levels in TTP: the effect of plasma exchange and correlation with response to treatment. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McGovern, UB; Francis, RE; Peck, B; Guest, SK; Wang, J; Myatt, SS; Krol, J; (2009) Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther , 8 (3) pp. 582-591. 10.1158/1535-7163.MCT-08-0805.

Meng, S; Arbit, T; Veeriah, S; Mellinghoff, IK; Fang, F; Vivanco, I; Rohle, D; (2009) 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. Cell Cycle , 8 (14) pp. 2238-2246. 10.4161/cc.8.14.8998.

Meyer, T; Gaya, AM; Dancey, G; Stratford, MRL; Othman, S; Sharma, SK; Wellsted, D; (2009) A Phase I Trial of Radioimmunotherapy with I-131-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas. CLIN CANCER RES , 15 (13) 4484 - 4492. 10.1158/1078-0432.CCR-09-0035.

Michelagnoli, M; Kotecha, K; Anazado, A; Flanagan, A; Tirabosco, R; Briggs, T; Cannon, S; (2009) OUTLOOK FOR CHILDREN UNDER 13 YEARS WITH PRIMARY MALIGNANT BONE TUMOURS - THE LONDON SARCOMA SERVICE EXPERIENCE 1999-2009. PEDIATR BLOOD CANCER , 53 (5) 797 - 798.

Middleton, D; Gonzalez, F; Fernandez-Vina, M; Tiercy, J-M; Marsh, SGE; Aubrey, M; Bicalho, MG; (2009) A bioinformatics approach to ascertaining the rarity of HLA alleles. TISSUE ANTIGENS , 74 (6) pp. 480-485. 10.1111/j.1399-0039.2009.01361.x.

Miene, C; Klenow, S; Veeriah, S; Richling, E; Glei, M; (2009) Impact of apple polyphenols on GSTT2 gene expression, subsequent protection of DNA and modulation of proliferation using LT97 human colon adenoma cells. Mol Nutr Food Res , 53 (10) pp. 1254-1262. 10.1002/mnfr.200800444.

Moilanen, P; Korppi, M; Hovi, L; Chapgier, A; Feinberg, J; Kong, XF; Boisson-Dupuis, S; (2009) Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J , 28 (7) pp. 658-660. 10.1097/INF.0b013e318195092e.

Moisoi, N; Klupsch, K; Fedele, V; East, P; Sharma, S; Renton, A; Plun-Favreau, H; (2009) Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. CELL DEATH DIFFER , 16 (3) 449 - 464. 10.1038/cdd.2008.166.

Moore, P; Barlis, P; Spiro, J; Ghimire, G; Roughton, M; Di Mario, C; Wallis, W; (2009) A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents. JACC-CARDIOVASC INTE , 2 (5) 437 - 444. 10.1016/j.jcin.2009.01.010.

Morris, JR; Boutell, C; Keppler, M; Densham, R; Weekes, D; Alamshah, A; Butler, L; (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature , 462 (7275) pp. 886-890. 10.1038/nature08593.

Morris, T; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; Kazmi, M; (2009) Second Autologous Transplantation After Bortezomib-Based Re-induction Therapy: The UK Experience. CLINICAL LYMPHOMA & MYELOMA , 9 S40-S41.

Morris, T; Oakervee, H; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; (2009) The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. CLINICAL LYMPHOMA & MYELOMA , 9 S27-S27.

Morris, TCM; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; O'Dwyer, M; (2009) Bortezomib, adriamycin and dexamethasone for patients with refractory and relapsed myeloma - results from the PAD (Ireland) study. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL PUBLISHING, INC

Morris, TCM; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; Kazmi, M; (2009) Good response rates following second autologous transplantation after bortezomib-based re-induction therapy. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 87). WILEY-BLACKWELL PUBLISHING, INC

Murugaesu, N; Powles, T; Bestwick, J; Oliver, RT; Shamash, J; (2009) Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis. Osteoporos Int , 20 (9) pp. 1627-1630. 10.1007/s00198-008-0793-x.

Mustapa, MFM; Grosse, SM; Kudsiova, L; Elbs, M; Raiber, EA; Wong, JB; Brain, APR; (2009) Stabilized Integrin-Targeting Ternary LPD (Lipopolyplex) Vectors for Gene Delivery Designed To Disassemble Within the Target Cell. BIOCONJUGATE CHEM , 20 (3) 518 - 532. 10.1021/bc800450r.


Nagao, K; Ginhoux, F; Leitner, WW; Motegi, S-I; Bennett, CL; Clausen, BE; Merad, M; (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (9) pp. 3312-3317. 10.1073/pnas.0807126106.

Nariculam, J; Freeman, A; Bott, S; Munson, P; Cable, N; Brookman-Amissah, N; Williamson, M; (2009) Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors. ASIAN J ANDROL , 11 (1) 109 - 118. 10.1038/aja.2008.22.

Nathwani, AC; Cochrane, M; McIntosh, J; Ng, CYC; Zhou, J; Gray, JT; Davidoff, AM; (2009) Enhancing transduction of the liver by adeno-associated viral vectors. GENE THER , 16 (1) 60 - 69. 10.1038/gt.2008.137.

Natkunam, Y; Tedoldi, S; Paterson, JC; Zhao, S; Rodriguez-Justo, M; Beck, AH; Siebert, R; (2009) Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am J Clin Pathol , 132 (3) pp. 361-371. 10.1309/AJCPEAGDKLWDMB1O.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability (Part 1): Coronary Angiography. J COMPUT ASSIST TOMO , 33 (2) 161 - 168.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability, Part 2: Global and Regional Ventricular Function, Mass, and First Pass Perfusion. J COMPUT ASSIST TOMO , 33 (2) 169 - 174.

Nikitenko, LL; (2009) Vascular endothelium in cancer. CELL TISSUE RES , 335 (1) 223 - 240. 10.1007/s00441-008-0707-4.

Nimmo, RA; Slack, FJ; (2009) An elegant miRror: microRNAs in stem cells, developmental timing and cancer. CHROMOSOMA , 118 (4) pp. 405-418. 10.1007/s00412-009-0210-z.

Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; Beck, S; (2009) Placenta-specific methylation of the vitamin d 24-hydroxylase gene implications for feedback autoregulation of active vitamin d levels at the fetomaternal interface. The journal of biological chemistry , 284 (22) 14838 - 14848. 10.1074/jbc.M809542200. Green open access

Novakovic, B.; Sibson, M.; Ng, H.K.; Manuelpillai, U.; Rakyan, V.; Down, T.; Beck, S.; (2009) Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. Journal of Biological Chemistry , 284 (22) pp. 14838-14848. 10.1074/jbc.M809542200. Green open access


O' Reilly, LA; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; Haynes, NM; (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature , 461 (7264) pp. 659-663. 10.1038/nature08402.

O'Donnell, G; Poeschl, R; Zimhony, O; Gunaratnam, M; Moreira, JBC; Neidle, S; Evangelopoulos, D; (2009) Bioactive Pyridine-N-oxide Disulfides from Allium stipitatum. JOURNAL OF NATURAL PRODUCTS , 72 (3) pp. 360-365. 10.1021/np800572r.

Olmos, D; Arkenau, HT; Ang, JE; Ledaki, I; Attard, G; Carden, CP; Reid, AH; (2009) Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol , 20 (1) pp. 27-33. 10.1093/annonc/mdn544.

Ooi, SKT; O'Donnell, AH; Bestor, TH; (2009) Mammalian cytosine methylation at a glance. J CELL SCI , 122 (16) 2787 - 2791. 10.1242/jcs.015123.

Orti, G; Lowdell, M; Fielding, A; Samuel, E; Pang, K; Kottaridis, P; Morris, E; (2009) Phase I Study of High-Stringency CD8 Depletion of Donor Leukocyte Infusions After Allogeneic Hematopoietic Stem Cell Transplantation. TRANSPLANTATION , 88 (11) 1312 - 1318. 10.1097/TP.0b013e3181bbf382.

Osman, E; Evans, V; Graham, IR; Athanasopoulos, T; McIntosh, J; Nathwani, AC; Simons, JP; (2009) Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice. ATHEROSCLEROSIS , 204 (1) 121 - 126. 10.1016/j.atherosclerosis.2008.08.043.


Panasyuk, G; Nemazanyy, I; Zhyvoloup, A; Filonenko, V; Davies, D; Robson, M; Pedley, RB; (2009) mTOR beta Splicing Isoform Promotes Cell Proliferation and Tumorigenesis. J BIOL CHEM , 284 (45) 30807 - 30814. 10.1074/jbc.M109.056085. Gold open access

Pankhurst, T; Lepenies, J; Nightingale, P; Howie, AJ; Adu, D; Harper, L; (2009) Vasculitic IgA nephropathy: prognosis and outcome. Nephron Clin Pract , 112 (1) c16-c24. 10.1159/000210570.

Papageorgiou, EA; Fiegler, H; Rakyan, V; Beck, S; Hulten, M; Lamnissou, K; Carter, NP; (2009) Sites of Differential DNA Methylation between Placenta and Peripheral Blood Molecular Markers for Noninvasive Prenatal Diagnosis of Aneuploidies. AM J PATHOL , 174 (5) 1609 - 1618. 10.2353/ajpath.2009.081038.

Patel, B; Buck, G; Mortuza, Y; Rai, L; Mitchell, W; Gerrard, G; Hoffbrand, AV; (2009) Minimal residual disease is a significant predictor of treatment failure in B lineage adult ALL: final results of the international trial UKALL XII:ECOG 2993. BRITISH JOURNAL OF HAEMATOLOGY , 145 p. 44.

Patel, B; Ghorani, E; Zhang, Y; Gitendra-Wickremasinghe, R; Steele, A; Fielding, AK; (2009) Attenuated Measles Virus: A Promising Therapeutic Modality for B Cell Malignancy. In: BLOOD. (pp. 970 - 970). AMER SOC HEMATOLOGY

Patel, B; Kirkland, KE; Szydlo, R; Pearce, RM; Clark, RE; Craddock, C; Liakopoulou, E; (2009) Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission. HAEMATOL-HEMATOL J , 94 (10) 1399 - 1406. 10.3324/haematol.2009.008649. Gold open access

Paten, B; Herrero, J; Beal, K; Birney, E; (2009) Sequence progressive alignment, a framework for practical large-scale probabilistic consistency alignment. Bioinformatics , 25 (3) pp. 295-301. 10.1093/bioinformatics/btn630.

Patkar, V; Acosta, D; Fox, J; Davidson, T; Keshtgar, M; Jones, A; (2009) A Novel Evidence-Adaptive Computerised Decision Support System for Breast Cancer Multidisciplinary Meetings: Results of an Evaluation Study. In: CANCER RESEARCH. (pp. 805S - 805S). AMER ASSOC CANCER RESEARCH

Peggs, KS; (2009) Adoptive T cell immunotherapy for cytomegalovirus. EXPERT OPIN BIOL TH , 9 (6) 725 - 736. 10.1517/14712590902967588.

Peggs, KS; Krauss, AC; Mackall, CL; (2009) Clinical implications of immune reconstitution following hematopoietic stem cell transplantation. Cancer Treat Res , 144 pp. 131-154. 10.1007/978-0-387-78580-6_6.

Peggs, KS; Quezada, SA; Allison, JP; (2009) Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. CLIN EXP IMMUNOL , 157 (1) 9 - 19. 10.1111/j.1365-2249.2009.03912.x.

Peggs, KS; Quezada, SA; Chambers, CA; Korman, AJ; Allison, JP; (2009) Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J EXP MED , 206 (8) 1717 - 1725. 10.1084/jem.20082492.

Peggs, KS; Thomson, K; Morris, E; Chowdhry, N; Verfuerth, S; Kottaridis, P; Goldstone, AH; (2009) Donor Lymphocyte Infusions Induce High Response Rates and Durable Salvage in Relapsed Hodgkin Lymphoma Post T Cell Depleted Allogeneic Transplantation. In: BLOOD. (pp. 87 - 87). AMER SOC HEMATOLOGY

Peggs, KS; Verfuerth, S; Pizzey, A; Chow, SLC; Thomson, K; Mackinnon, S; (2009) Cytomegalovirus-Specific T Cell Immunotherapy Promotes Restoration of Durable Functional Antiviral Immunity following Allogeneic Stem Cell Transplantation. CLIN INFECT DIS , 49 (12) 1851 - 1860. 10.1086/648422.

Pellagatti, A; Marafioti, T; Paterson, JC; Malcovati, L; Della Porta, MG; Jädersten, M; Pushkaran, B; (2009) Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. Br J Haematol , 146 (1) pp. 86-90. 10.1111/j.1365-2141.2009.07720.x.


Percy, LA; Rabin, N; Cheesman, S; Mohamedbhai, S; Yong, K; (2009) Bortezomib in Real Patients: A Single-Center Experience. CLIN LYMPHOMA MYELOM , 9 S38 - S39.

Peters, FH; Brunell, C; Benjamin, E; (2009) Massive ovarian edema and contralateral mature cystic teratoma: asymptomatic presentation in a premenarchal female. J Pediatr Adolesc Gynecol , 22 (5) e118-e120. 10.1016/j.jpag.2008.09.005.

Plummer, R; Vidal, L; Griffin, M; Lesley, M; de Bono, J; Coulthard, S; Sludden, J; (2009) Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (9) 3177 - 3183. 10.1158/1078-0432.CCR-08-2859.

Pollard, SM; Yoshikawa, K; Clarke, ID; Danovi, D; Stricker, S; Russell, R; Bayani, J; (2009) Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens. CELL STEM CELL , 4 (6) 568 - 580. 10.1016/j.stem.2009.03.014.

Popat, R; Oakervee, H; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; (2009) Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY , 144 (6) pp. 887-894. 10.1111/j.1365-2141.2008.07572.x.

Porter, J; (2009) Blood transfusion: quality and safety issues in thalassemia, basic requirements and new trends. Hemoglobin , 33 Sup S28-S36. 10.3109/03630260903346593.

Porter, JB; (2009) Optimizing iron chelation strategies in beta-thalassaemia major. BLOOD REVIEWS , 23 S3 - S7.

Porter, JB; (2009) Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease. Hemoglobin , 33 Sup S37-S45. 10.3109/03630260903346627.

Postel-Vinay, S; Arkenau, HT; Olmos, D; Ang, J; Barriuso, J; Ashley, S; Banerji, U; (2009) Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter? In: (pp. pp. 1373-1378).

Presneau, N; Shalaby, A; Idowu, B; Gikas, P; Cannon, SR; Gout, I; Diss, T; (2009) Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway. BRIT J CANCER , 100 (9) 1406 - 1414. 10.1038/sj.bjc.6605019.

Privitera, A; Milkhu, CS; Datta, V; Rodriguez-Justo, M; Windsor, A; Cohen, CR; (2009) Actinomycosis of the sigmoid colon: A case report. World Journal of Gastrointestinal Surgery , 1 (1) 62 - 64. 10.4240/wjgs.v1.i1.62. Green open access

Punwani, S; Rodriguez-Justo, M; Bainbridge, A; Greenhalgh, R; De Vita, E; Bloom, S; Cohen, R; (2009) Mural Inflammation in Crohn Disease: Location-Matched Histologic Validation of MR Imaging Features. RADIOLOGY , 252 (3) 712 - 720. 10.1148/radiol.2523082167.


Querol, S; Mufti, GJ; Marsh, SGE; Pagliuca, A; Little, AM; Shaw, BE; Jeffery, R; (2009) Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be? HAEMATOL-HEMATOL J , 94 (4) 536 - 541. 10.3324/haematol.2008.002741. Gold open access

Querol, S; Rubinstein, P; Marsh, SGE; Goldman, J; Madrigal, JA; (2009) Cord blood banking: 'providing cord blood banking for a nation'. BRITISH JOURNAL OF HAEMATOLOGY , 147 (2) pp. 227-235. 10.1111/j.1365-2141.2009.07818.x.

Quinn, J; Glassford, J; Percy, L; Munson, P; Rodriguez-Justo, M; Marafioti, T; Yong, K; (2009) Proliferative Effect of APRIL On Primary Multiple Myeloma Cells Is Dictated by D-Type Cyclin Group and Translocation Status. In: BLOOD. (pp. 56 - 56). AMER SOC HEMATOLOGY

Quinn, J; Rabin, N; Rodriguez-Justo, M; Choi, D; Yong, K; (2009) Multiple myeloma presenting with spinal cord compression during pregnancy. ANNALS OF HEMATOLOGY , 88 (2) pp. 181-182. 10.1007/s00277-008-0558-9.

Quinn, J; Rabin, N; Rodriguez-Justo, M; Choi, D; Yong, K; (2009) Multiple myeloma presenting with spinal cord compression during pregnancy. ANN HEMATOL , 88 (2) 181 - 182. 10.1007/s00277-008-0558-9.

Quinn, J; Von Klemperer, K; Brooks, R; Peebles, D; Walker, F; Cohen, H; (2009) Use of high intensity adjusted dose low molecular weight heparin in women with mechanical heart valves during pregnancy: a single-center experience. HAEMATOL-HEMATOL J , 94 (11) 1608 - 1612. 10.3324/haematol.2008.002840. Gold open access


Rahim, AA; Wong, AM; Buckley, SM; Hughes, DA; Karlsson, S; Cooper, JD; Thrasher, AJ; (2009) Fetal Gene Therapy for Acute Neuronopathic Gaucher Disease. In: MOLECULAR THERAPY. (pp. S357 - S357). NATURE PUBLISHING GROUP

Rahman, KM; Reszka, AP; Gunaratnam, M; Haider, SM; Howard, PW; Fox, KR; Neidle, S; (2009) Biaryl polyamides as a new class of DNA quadruplex-binding ligands. Chem Commun (Camb) (27) 4097 - 4099. 10.1039/b902359c.

Regad, T; Bellodi, C; Nicotera, P; Salomoni, P; (2009) The tumor suppressor Pml regulates cell fate in the developing neocortex. NAT NEUROSCI , 12 (2) 132 - 140. 10.1038/nn.2251.

Riddell, AF; Gomez, K; Millar, CM; Mellars, G; Gill, S; Brown, SA; Sutherland, M; (2009) Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. Blood , 114 (16) pp. 3489-3496.

Ringland, CL; Arkenau, HT; O'Connell, DL; Ward, RL; (2009) Second primary colorectal cancers (SPCRCs): Experiences from a large Australian cancer registry. Annals of Oncology , 21 (1) pp. 92-97. 10.1093/annonc/mdp288.

Robey, RC; Lagos, D; Gratrix, F; Henderson, S; Matthews, NC; Vart, RJ; Bower, M; (2009) The CD8 and CD4 T-Cell Response against Kaposi's Sarcoma-Associated Herpesvirus Is Skewed Towards Early and Late Lytic Antigens. PLOS ONE , 4 (6) , Article e5890. 10.1371/journal.pone.0005890. Green open access

Robinson, J; Roberts, CH; Dodi, IA; Madrigal, JA; Pawelec, G; Wedel, L; Marsh, SGE; (2009) The European searchable tumour line database. CANCER IMMUNOLOGY IMMUNOTHERAPY , 58 (9) pp. 1501-1506. 10.1007/s00262-008-0656-5.

Robinson, J; Waller, MJ; Fail, SC; McWilliam, H; Lopez, R; Parham, P; Marsh, SGE; (2009) The IMGT/HLA database. NUCLEIC ACIDS RESEARCH , 37 D1013-D1017. 10.1093/nar/gkn662.

Rocha, R; Vassallo, J; Soares, F; Miller, K; Gobbi, H; (2009) Digital slides: Present status of a tool for consultation, teaching, and quality control in pathology. PATHOL RES PRACT , 205 (11) 735 - 741. 10.1016/j.prp.2009.05.004.

Rocha, RM; Miller, K; Soares, F; Schenka, N; Vassallo, J; Gobbi, H; (2009) Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer. J CLIN PATHOL , 62 (8) 699 - 704. 10.1136/jcp.2009.065326.

Roddie, C; Paul, JPV; Benjamin, R; Gallimore, CI; Xerry, J; Gray, JJ; Peggs, KS; (2009) Allogeneic Hematopoietic Stem Cell Transplantation and Norovirus Gastroenteritis: A Previously Unrecognized Cause of Morbidity. CLIN INFECT DIS , 49 (7) 1061 - 1068. 10.1086/605557.

Rodriguez-Justo, M; Attygalle, AD; Munson, P; Roncador, G; Marafioti, T; Piris, MA; (2009) Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. MODERN PATHOLOGY , 22 (6) pp. 753-761. 10.1038/modpathol.2009.12.

Rodríguez-Mateos, M; Abia, D; García-Gómez, JJ; Morreale, A; de la Cruz, J; Santos, C; Remacha, M; (2009) The amino terminal domain from Mrt4 protein can functionally replace the RNA binding domain of the ribosomal P0 protein. Nucleic Acids Res , 37 (11) pp. 3514-3521. 10.1093/nar/gkp209.

Ross, J; Bottardi, S; Bourgoin, V; Wollenschlaeger, A; Drobetsky, E; Trudel, M; Milot, E; (2009) Differential requirement of a distal regulatory region for pre-initiation complex formation at globin gene promoters. NUCLEIC ACIDS RES , 37 (16) 5295 - 5308. 10.1093/nar/gkp545. Gold open access

Rossi, M; Munarriz, ER; Bartesaghi, S; Milanese, M; Dinsdale, D; Guerra-Martin, MA; Bampton, ETW; (2009) Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux. J CELL SCI , 122 (18) 3330 - 3339. 10.1242/jcs.048181.

Ryland, JK; Lawrie, AS; Machin, SJ; Mackie, IJ; (2009) Persistent high factor VIII activity leading to increased thrombin generation. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 4 - 4). WILEY-BLACKWELL PUBLISHING, INC


Sainsbury, R; Proctor, I; Rodriguez, S; Loddo, M; Tudzarova, S; Stoeber, K; Williams, G; (2009) Targeting DNA Replication before It Starts: Cdc7 as a Therapeutic Target in p53 Mutant Her2 and Triple Negative Breast Ca. In: CANCER RESEARCH. (pp. 640S - 640S). AMER ASSOC CANCER RESEARCH

Salma, Y; Lafont, E; Therville, N; Carpentier, S; Bonnafé, MJ; Levade, T; Génisson, Y; (2009) The natural marine anhydrophytosphingosine, Jaspine B, induces apoptosis in melanoma cells by interfering with ceramide metabolism. Biochem Pharmacol , 78 (5) pp. 477-485. 10.1016/j.bcp.2009.05.002.

Salomoni, P; (2009) Stemming out of a new PML era? CELL DEATH DIFFER , 16 (8) 1083 - 1092. 10.1038/cdd.2009.63.

Salomoni, P; Calabretta, B; (2009) Targeted therapies and autophagy New insights from chronic myeloid leukemia. AUTOPHAGY , 5 (7) 1050 - 1051.

Salomoni, P; Michod, D; (2009) End of the Daxx diatribe? CELL CYCLE , 8 (10) 1467 - 1468.

Sampath, D; Calin, GA; Puduvalli, VK; Gopisetty, G; Taccioli, C; Liu, CG; Ewald, B; (2009) Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. BLOOD , 113 (16) 3744 - 3753. 10.1182/blood-2008-09-178707.

Sandanayake, NS; Church, NI; Chapman, MH; Johnson, GJ; Dhar, DK; Amin, Z; Deheragoda, MG; (2009) Presentation and Management of Post-treatment Relapse in Autoimmune Pancreatitis/Immunoglobulin G4-Associated Cholangitis. CLIN GASTROENTEROL H , 7 (10) 1089 - 1096. 10.1016/j.cgh.2009.03.021.

Sandhu, J; Kaur, B; Armstrong, C; Talbot, CJ; Steward, WP; Farmer, PB; Singh, R; (2009) Determination of 5-methyl-2'-deoxycytidine in genomic DNA using high performance liquid chromatography-ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci , 877 (20-21) pp. 1957-1961. 10.1016/j.jchromb.2009.05.032.

Saunders, RE; Shiltagh, N; Gomez, K; Mellars, G; Cooper, C; Perry, DJ; Tuddenham, EG; (2009) Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency. THROMB HAEMOSTASIS , 102 (2) 287 - 301. 10.1160/TH09-01-0044.

Seymour, LW; Ferry, DR; Kerr, DJ; Rea, D; Whitlock, M; Poyner, R; Boivin, C; (2009) Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. INT J ONCOL , 34 (6) 1629 - 1636. 10.3892/ijo_00000293.

Shalaby, AAE; Presneau, N; Idowu, BD; Thompson, L; Briggs, TRW; Tirabosco, R; Diss, TC; (2009) Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas. MODERN PATHOL , 22 (8) 996 - 1005. 10.1038/modpathol.2009.63.

Sharpe, LR; Ancliff, P; Amrolia, P; Gilmour, KC; Vellodi, A; (2009) Type II Gaucher disease manifesting as haemophagocytic lymphohistiocytosis. J Inherit Metab Dis , 32 Sup S107-S110. 10.1007/s10545-009-1091-2.

Shaw, BE; Veys, P; Pagliuca, A; Addada, J; Cook, G; Craddock, CF; Gennery, AR; (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. BONE MARROW TRANSPL , 44 (1) 7 - 12. 10.1038/bmt.2008.420.

Shaw, BE; Veys, P; Pagliuca, A; Addada, J; Cook, G; Craddock, CF; Gennery, AR; (2009) Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant. , 44 (1) pp. 7-12.

Shi, Y; Zhu, J; Salomoni, P; Tucci, P; Lu, X; (2009) A Sino-British frontier workshop of cancer biology. CELL DEATH DIFFER , 16 (4) 648 - 650. 10.1038/cdd.2008.192.

Shih, CS; Laurie, N; Holzmacher, J; Spence, Y; Nathwani, AC; Davidoff, AM; Dyer, MA; (2009) AAV-mediated Local Delivery of Interferon-beta for the Treatment of Retinoblastoma in Preclinical Models. NEUROMOL MED , 11 (1) 43 - 52. 10.1007/s12017-009-8059-0.

Shuldham, C; Parkin, C; Firouzi, A; Roughton, M; Lau-Walker, M; (2009) The relationship between nurse staffing and patient outcomes: A case study. INT J NURS STUD , 46 (7) 986 - 992. 10.1016/j.ijnurstu.2008.06.004.

Siddle, H.V.; Deakin, J.E.; Coggill, P.; Hart, E.; Cheng, Y.; Wong, E.S.W.; Harrow, J.; (2009) MHC-linked and un-linked class I genes in the wallaby. BMC Genomics , 10 (1) , Article 310. 10.1186/1471-2164-10-310. Green open access

Skibola, CF; Bracci, PM; Halperin, E; Conde, L; Craig, DW; Agana, L; Iyadurai, K; (2009) Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet , 41 (8) pp. 873-875. 10.1038/ng.419.

Smith, BN; Ancliff, PJ; Pizzey, A; Khwaja, A; Linch, DC; Gale, RE; (2009) Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. BRIT J HAEMATOL , 144 (5) 762 - 770. 10.1111/j.1365-2141.2008.07493.x.

Smith, N; Hayee, B; Evans, C; Ancliff, P; Hall, G; Segal, A; Linch, D; (2009) Novel G6Pc3 Mutations Identified in Autosomal Recessive Scn Patients with and Without Congenital Abnormalities. Haematologica-the Hematology Journal , 94 0604-. Gold open access

Srirajaskanthan, R; McStay, M; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review. Neuroendocrinology , 89 (1) pp. 48-55. 10.1159/000151222.

Srirajaskanthan, R; Toumpanakis, C; Karpathakis, A; Marelli, L; Quigley, AM; Dusmet, M; Meyer, T; (2009) Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients. Lung Cancer , 65 (1) pp. 68-73. 10.1016/j.lungcan.2008.10.025.

Srirajaskanthan, R; Toumpanakis, C; Meyer, T; Caplin, ME; (2009) Review article: future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumours. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , 29 (11) pp. 1143-1154. 10.1111/j.1365-2036.2009.03988.x.

Stavroulis, AI; Saridogan, E; Benjamin, E; Cutner, AS; (2009) Can high histological confirmation rates be achieved for pelvic endometriosis? JOURNAL OF OBSTETRICS AND GYNAECOLOGY , 29 (8) pp. 729-731. 10.3109/01443610903165537.

Steele, AJ; Prentice, AG; Cwynarski, K; Hoffbrand, AV; Wickremasinghe, RG; (2009) 2-phenylacetylenesulphonamide induces p53-independent apoptosis of CLL cells via upregulation of the BH3 protein Noxa. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 1 - 1). WILEY-BLACKWELL PUBLISHING, INC

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; (2009) 2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. Blood , 114 (6) pp. 1217-1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; (2009) 2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells. BLOOD , 114 (6) 1217 - 1225. 10.1182/blood-2008-11-190587.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; Hart, SM; Lowdell, MW; Samuel, ER; (2009) 2-phenylacetylenesulfonamide(PAS) induces p53-independent killing of B-chronic lymphocytic leukemia(CLL) cells. Blood , 114 (6) pp. 1217-1225.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Yogashangary, BC; North, JM; Nacheva, EP; Chanalaris, A; (2009) 2-phenylacetylenesulfonamise(PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia cells (CLL) cells. Blood , 114 (6) pp. 1217-1225.

Steier, J; Jolley, CJ; Seymour, J; Roughton, M; Polkey, MI; Moxham, J; (2009) Neural respiratory drive in obesity. THORAX , 64 (8) 719 - 725. 10.1136/thx.2008.109728.

Stieger, K; Lhériteau, E; Moullier, P; Rolling, F; (2009) AAV-mediated gene therapy for retinal disorders in large animal models. ILAR J , 50 (2) pp. 206-224.

Sun, Y; Kong, W; Falk, A; Hu, J; Zhou, L; Pollard, S; Smith, A; (2009) CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS One , 4 (5) , Article e5498. 10.1371/journal.pone.0005498. Green open access

Swanton, C; Burrell, RA; (2009) Advances in personalized therapeutics in non-small cell lung cancer: 4q12 amplification, PDGFRA oncogene addiction and sunitinib sensitivity. Cancer Biol Ther , 8 (21) pp. 2051-2053.

Swanton, C; Caldas, C; (2009) Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer , 100 (10) pp. 1517-1522. 10.1038/sj.bjc.6605031.

Swanton, C; Nicke, B; Schuett, M; Eklund, AC; Ng, C; Li, Q; Hardcastle, T; (2009) Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A , 106 (21) pp. 8671-8676. 10.1073/pnas.0811835106.


Taccioli, C; Fabbri, E; Visone, R; Volinia, S; Calin, GA; Fong, LY; Gambari, R; (2009) UCbase & miRfunc: a database of ultraconserved sequences and microRNA function. NUCLEIC ACIDS RES , 37 D41 - D48. 10.1093/nar/gkn702. Gold open access

Taccioli, C; Wan, SG; Liu, CG; Alder, H; Volinia, S; Farber, JL; Croce, CM; (2009) Zinc Replenishment Reverses Overexpression of the Proinflammatory Mediator S100A8 and Esophageal Preneoplasia in the Rat. GASTROENTEROLOGY , 136 (3) 953 - 966. 10.1053/j.gastro.2008.11.039.

Taher, A; Cappellini, MD; Vichinsky, E; Galanello, R; Piga, A; Lawniczek, T; Clark, J; (2009) Efficacy and safety of deferasirox doses of > 30 mg/kg per d in patients with transfusion-dependent anaemia and iron overload. BRIT J HAEMATOL , 147 (5) 752 - 759. 10.1111/j.1365-2141.2009.07908.x.

Tan, M. H.; Smith, A. J.; Pawlyk, B.; Xu, X.; Liu, X.; Bainbridge, J. B.; Basche, M.; (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) pp. 2099-2114. 10.1093/hmg/ddp133. Green open access

Tan, MH; Smith, AJ; Pawlyk, B; Xu, XY; Liu, XQ; Bainbridge, JB; Basche, M; (2009) Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectors. Human Molecular Genetics , 18 (12) 2099 - 2114. 10.1093/hmg/ddp133. Green open access

Taylor, SA; Punwani, S; Rodriguez-Justo, M; Bainbridge, A; Greenhalgh, R; De Vita, E; Forbes, A; (2009) Mural Crohn Disease: Correlation of Dynamic Contrast-enhanced MR Imaging Findings with Angiogenesis and Inflammation at Histologic Examination-Pilot Study. RADIOLOGY , 251 (2) 369 - 379. 10.1148/radiol.2512081292.

Teschendorff, AE; Menon, U; Gentry-Maharaj, A; Ramus, SJ; Gayther, SA; Apostolidou, S; Jones, A; (2009) An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer. PLOS ONE , 4 (12) , Article e8274. 10.1371/journal.pone.0008274. Green open access

Thephinlap, C; Phisalaphong, C; Fucharoen, S; Porter, JB; Srichairatanakool, S; (2009) Efficacy of Curcuminoids in Alleviation of Iron Overload and Lipid Peroxidation in Thalassemic Mice. MED CHEM , 5 (5) 474 - 482.

Thind, A; Freeman, T; Thorpe, C; Burt, A; Stewart, M; (2009) Family physicians' satisfaction with current practice: what is the role of their interactions with specialists? Healthc Policy , 4 (3) e145-e158.

Thoma, CR; Toso, A; Gutbrodt, KL; Reggi, SP; Frew, IJ; Schraml, P; Hergovich, A; (2009) VHL loss causes spindle misorientation and chromosome instability. NAT CELL BIOL , 11 (8) 994 - U200. 10.1038/ncb1912.

Thomson, KJ; Morris, EC; Bloor, A; Cook, G; Milligan, D; Parker, A; Clark, F; (2009) Favorable Long-Term Survival After Reduced-Intensity Allogeneic Transplantation for Multiple-Relapse Aggressive Non-Hodgkin's Lymphoma. Journal of Clinical Oncology , 27 (3) 426 - 432. 10.1200/JCO.2008.17.3328.

Tipping, AJ; Pina, C; Castor, A; Hong, DL; Rodrigues, NP; Lazzari, L; May, GE; (2009) High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. BLOOD , 113 (12) 2661 - 2672. 10.1182/blood-2008-06-161117.

Tirabosco, R; Lang-Lazdunski, L; Diss, TC; Amary, MFC; Rodriguez-Justo, M; Landau, D; Lorenzi, W; (2009) Clear cell sarcoma of the mediastinum. ANNALS OF DIAGNOSTIC PATHOLOGY , 13 (3) pp. 197-200. 10.1016/j.anndiagpath.2008.02.014.

Tosello, V; Mansour, MR; Barnes, K; Paganin, M; Sulis, ML; Jenkinson, S; Allen, CG; (2009) WT1 mutations in T-ALL. BLOOD , 114 (5) 1038 - 1045. 10.1182/blood-2008-12-192039.

Townsend, W; Cross, NCP; Waghorn, K; Somana, K; Ramsay, A; Thomson, K; Peggs, K; (2009) Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder. BONE MARROW TRANSPL , 44 (3) 197 - 199. 10.1038/bmt.2008.448.

Tulpule, S; Shaw, BE; Makoni, P; Little, AM; Madrigal, JA; Goldman, JM; (2009) Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. BONE MARROW TRANSPL , 44 (2) 129 - 130. 10.1038/bmt.2008.438.


Valle, JW; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; Baka, S; (2009) Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. BRIT J CANCER , 101 (4) 621 - 627. 10.1038/sj.bjc.6605211.

Van Cutsem, E; Rivera, F; Berry, S; Kretzschmar, A; Michael, M; DiBartolomeo, M; Mazier, MA; (2009) Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. Ann Oncol , 20 (11) pp. 1842-1847. 10.1093/annonc/mdp233.

Veeriah, S; Brennan, C; Meng, S; Singh, B; Fagin, JA; Solit, DB; Paty, PB; (2009) The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci U S A , 106 (23) pp. 9435-9440. 10.1073/pnas.0900571106.

Velica, P; Davies, NJ; Rocha, PP; Schrewe, H; Ride, JP; Bunce, CM; (2009) Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers. MOL CANCER , 8 , Article 121. 10.1186/1476-4598-8-121. Gold open access

Vergote, I; Calvert, H; Kania, M; Kaiser, C; Zimmermann, AH; Sehouli, J; (2009) A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer. EUR J CANCER , 45 (8) 1415 - 1423. 10.1016/j.ejca.2008.12.013.

Virgili, A; Brazma, D; Grace, C; Nacheva, EP; (2009) Deletions of the Normal ABL1 at the Non-Translocated Chromosome 9 in CML Associated with TKI Resistance. In: BLOOD. (pp. 1260 - 1260). AMER SOC HEMATOLOGY

Visone, R; Rassenti, LZ; Veronese, A; Taccioli, C; Costinean, S; Aguda, BD; Volinia, S; (2009) Karyotype-specific microRNA signature in chronic lymphocytic leukemia. BLOOD , 114 (18) 3872 - 3879. 10.1182/blood-2009-06-229211.

Vladimirou, E; Li, M; Aldridge, CP; Frigerio, L; Kirkilionis, M; Robinson, C; (2009) Diffusion of a membrane protein, Tat subunit Hcf106, is highly restricted within the chloroplast thylakoid network. FEBS Lett , 583 (22) pp. 3690-3696. 10.1016/j.febslet.2009.10.057.

van Veldhuisen, DJ; Cohen-Solal, A; Bohm, M; Anker, SD; Babalis, D; Roughton, M; Coats, AJS; (2009) Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J AM COLL CARDIOL , 53 (23) 2150 - 2158. 10.1016/j.jacc.2009.02.046.

von Minckwitz, G; du Bois, A; Schmidt, M; Maass, N; Cufer, T; de Jongh, FE; Maartense, E; (2009) Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. J Clin Oncol , 27 (12) pp. 1999-2006. 10.1200/JCO.2008.19.6618.


Wang, D; Zhang, S; He, F; Zhu, J; Hu, S; Yu, J; (2009) How do variable substitution rates influence Ka and Ks calculations? Genomics Proteomics Bioinformatics , 7 (3) pp. 116-127. 10.1016/S1672-0229(08)60040-6.

Werbowetski-Ogilvie, TE; Bosse, M; Stewart, M; Schnerch, A; Ramos-Mejia, V; Rouleau, A; Wynder, T; (2009) Characterization of human embryonic stem cells with features of neoplastic progression. NATURE BIOTECHNOLOGY , 27 (1) pp. 91-97. 10.1038/nbt.1516.

Westrate, L; Mackay, H; Brown, T; Nguyen, B; Kluza, J; Wilson, WD; Lee, M; (2009) Effects of the N-Terminal Acylamido Group of Imidazole- and Pyrrole-Containing Polyamides on DNA Sequence Specificity and Binding Affinity. BIOCHEMISTRY-US , 48 (24) 5679 - 5688. 10.1021/bi900242t.

Wiegant, FA; Surinova, S; Ytsma, E; Langelaar-Makkinje, M; Wikman, G; Post, JA; (2009) Plant adaptogens increase lifespan and stress resistance in C. elegans. Biogerontology , 10 (1) pp. 27-42. 10.1007/s10522-008-9151-9.

Windsor, R; Strauss, S; Seddon, B; Whelan, J; (2009) Experimental therapies in Ewing's sarcoma. EXPERT OPIN INV DRUG , 18 (2) 143 - 159. 10.1517/13543780802715784.

Wood-Kaczmar, A; Gandhi, S; Yao, Z; Abramov, AY; Miljan, EA; Keen, G; Stanyer, L; (2009) PINK1 is necessary for long term survival and mitochondrial function in primary human dopaminergic neurons. In: JOURNAL OF NEUROCHEMISTRY. (pp. 301 - 302). WILEY-BLACKWELL PUBLISHING, INC

Wu, P; Davies, FE; Boyd, K; Thomas, K; Dines, S; Saso, RM; Potter, MN; (2009) The impact of extramedullary disease at presentation on the outcome of myeloma. LEUKEMIA LYMPHOMA , 50 (2) 230 - 235. 10.1080/10428190802657751.



Yong, M; Tolner, B; Nagl, S; Pedley, RB; Chester, K; Green, AJ; Mayer, A; (2009) Data standards for minimum information collection for antibody therapy experiments. PROTEIN ENG DES SEL , 22 (3) 221 - 224. 10.1093/protein/gzp003.


Zhang, EZ; Laufer, JG; Pedley, RB; Beard, PC; (2009) In vivo high-resolution 3D photoacoustic imaging of superficial vascular anatomy. PHYS MED BIOL , 54 (4) 1035 - 1046. 10.1088/0031-9155/54/4/014.

This list was generated on Sun Dec 4 06:32:38 2016 GMT.